Medindia

X

New Target for Lung Cancer Identified

by Sheela Philomena on  April 6, 2011 at 12:40 PM Cancer News   - G J E 4
Researchers have discovered a mutation in DDR2 gene that helps to identify which patients with squamous cell lung cancer will respond to a leukemia drug called dasatinib.
 New Target for Lung Cancer Identified
New Target for Lung Cancer Identified
Advertisement

According to lead researcher Matthew Meyerson, professor of pathology at the Dana Farber Cancer Institute, there are currently no targeted therapies for squamous cell lung cancer.

Advertisement
Using standard genetic sequencing techniques, Meyerson and colleagues identified mutations in the DDR2 kinase gene in about 3 percent of squamous cell lung cancers and cell lines.

Furthermore, they found that tumor cells with these DDR2 mutations responded to treatment with dasatinib.

A patient whose cancer carried a DDR2 mutation also showed a clinical response to dasatinib.

"Dasatinib is an existing therapy for chronic myelogenous leukemia with a long history and a strong safety profile," said Meyerson.

"The results of this study clearly encourage a clinical trial to test dasatinib in the setting of squamous cell lung cancer," he added.

The findings are published in Cancer Discovery.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All